nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0994	0.201	CbGbCtD
Estropipate—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0833	0.169	CbGbCtD
Estropipate—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0795	0.161	CbGbCtD
Estropipate—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0521	0.105	CbGbCtD
Estropipate—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0484	0.0981	CbGbCtD
Estropipate—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0389	0.0788	CbGbCtD
Estropipate—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0357	0.0722	CbGbCtD
Estropipate—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0222	0.045	CbGbCtD
Estropipate—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0204	0.0413	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0139	0.0281	CbGbCtD
Estropipate—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00515	0.129	CbGpPWpGaD
Estropipate—SLC22A1—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00227	0.0571	CbGpPWpGaD
Estropipate—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00207	0.052	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00151	0.0378	CbGpPWpGaD
Estropipate—SLC22A1—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.0013	0.0328	CbGpPWpGaD
Estropipate—Estriol—ABCB1—peripheral nervous system neoplasm	0.00115	0.264	CrCbGaD
Estropipate—Estramustine—ABCB1—peripheral nervous system neoplasm	0.00107	0.245	CrCbGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000803	0.0202	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00079	0.0198	CbGpPWpGaD
Estropipate—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000763	0.0192	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.000756	0.019	CbGpPWpGaD
Estropipate—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000674	0.0169	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000673	0.0169	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000658	0.0165	CbGpPWpGaD
Estropipate—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.000626	0.144	CrCbGaD
Estropipate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000563	0.0141	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.000558	0.014	CbGpPWpGaD
Estropipate—Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	0.000547	0.126	CrCbGaD
Estropipate—Estrone—ABCB1—peripheral nervous system neoplasm	0.000545	0.126	CrCbGaD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000502	0.0126	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000502	0.0126	CbGpPWpGaD
Estropipate—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000478	0.012	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000436	0.011	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000433	0.0109	CbGpPWpGaD
Estropipate—Estradiol—ABCB1—peripheral nervous system neoplasm	0.000413	0.0952	CrCbGaD
Estropipate—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	0.000405	0.0102	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000397	0.00998	CbGpPWpGaD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000395	0.00991	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00038	0.00955	CbGpPWpGaD
Estropipate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000375	0.000811	CcSEcCtD
Estropipate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000372	0.000806	CcSEcCtD
Estropipate—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000804	CcSEcCtD
Estropipate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000803	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000802	CcSEcCtD
Estropipate—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00037	0.0008	CcSEcCtD
Estropipate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.000796	CcSEcCtD
Estropipate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.000796	CcSEcCtD
Estropipate—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000796	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.000794	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.000794	CcSEcCtD
Estropipate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000367	0.000793	CcSEcCtD
Estropipate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000367	0.000793	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000792	CcSEcCtD
Estropipate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000364	0.000788	CcSEcCtD
Estropipate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000364	0.000787	CcSEcCtD
Estropipate—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000785	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000783	CcSEcCtD
Estropipate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000361	0.000781	CcSEcCtD
Estropipate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000361	0.000781	CcSEcCtD
Estropipate—Rash—Topotecan—peripheral nervous system neoplasm	0.000361	0.000781	CcSEcCtD
Estropipate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000361	0.00078	CcSEcCtD
Estropipate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00036	0.000778	CcSEcCtD
Estropipate—Cough—Etoposide—peripheral nervous system neoplasm	0.000359	0.000777	CcSEcCtD
Estropipate—Headache—Topotecan—peripheral nervous system neoplasm	0.000359	0.000776	CcSEcCtD
Estropipate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000358	0.000775	CcSEcCtD
Estropipate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.000775	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000358	0.000774	CcSEcCtD
Estropipate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000358	0.000774	CcSEcCtD
Estropipate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.000774	CcSEcCtD
Estropipate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000357	0.000773	CcSEcCtD
Estropipate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000356	0.000771	CcSEcCtD
Estropipate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000356	0.00077	CcSEcCtD
Estropipate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000356	0.00077	CcSEcCtD
Estropipate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000356	0.00077	CcSEcCtD
Estropipate—Pain—Vincristine—peripheral nervous system neoplasm	0.000355	0.000767	CcSEcCtD
Estropipate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000355	0.000767	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000767	CcSEcCtD
Estropipate—Rash—Melphalan—peripheral nervous system neoplasm	0.000353	0.000764	CcSEcCtD
Estropipate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000353	0.000764	CcSEcCtD
Estropipate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.000761	CcSEcCtD
Estropipate—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000755	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000348	0.000753	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000749	CcSEcCtD
Estropipate—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000344	0.00865	CbGpPWpGaD
Estropipate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000342	0.00074	CcSEcCtD
Estropipate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00074	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000341	0.00856	CbGpPWpGaD
Estropipate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000736	CcSEcCtD
Estropipate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.000736	CcSEcCtD
Estropipate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00034	0.000736	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000339	0.00852	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000339	0.00852	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000339	0.000734	CcSEcCtD
Estropipate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000337	0.00073	CcSEcCtD
Estropipate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000337	0.00073	CcSEcCtD
Estropipate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000336	0.000727	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000726	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000334	0.000723	CcSEcCtD
Estropipate—Infection—Etoposide—peripheral nervous system neoplasm	0.000334	0.000722	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000721	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000333	0.00072	CcSEcCtD
Estropipate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000333	0.00072	CcSEcCtD
Estropipate—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000716	CcSEcCtD
Estropipate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000716	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00033	0.00828	CbGpPWpGaD
Estropipate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000712	CcSEcCtD
Estropipate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000328	0.000709	CcSEcCtD
Estropipate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000328	0.000709	CcSEcCtD
Estropipate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000326	0.000706	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000702	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000324	0.00813	CbGpPWpGaD
Estropipate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000693	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000318	0.000687	CcSEcCtD
Estropipate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.000686	CcSEcCtD
Estropipate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000685	CcSEcCtD
Estropipate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000678	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00031	0.0078	CbGpPWpGaD
Estropipate—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00067	CcSEcCtD
Estropipate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000668	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000667	CcSEcCtD
Estropipate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000308	0.00774	CbGpPWpGaD
Estropipate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000666	CcSEcCtD
Estropipate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000663	CcSEcCtD
Estropipate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000663	CcSEcCtD
Estropipate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000305	0.000661	CcSEcCtD
Estropipate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.000659	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000302	0.000653	CcSEcCtD
Estropipate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000652	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000301	0.00755	CbGpPWpGaD
Estropipate—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.00065	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000646	CcSEcCtD
Estropipate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000299	0.000646	CcSEcCtD
Estropipate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000297	0.000644	CcSEcCtD
Estropipate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000639	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000639	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000295	0.000638	CcSEcCtD
Estropipate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000637	CcSEcCtD
Estropipate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.000633	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00029	0.000627	CcSEcCtD
Estropipate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00029	0.000627	CcSEcCtD
Estropipate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00029	0.000627	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000626	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000289	0.00725	CbGpPWpGaD
Estropipate—Pain—Etoposide—peripheral nervous system neoplasm	0.000287	0.000621	CcSEcCtD
Estropipate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000287	0.000621	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00062	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000616	CcSEcCtD
Estropipate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.000616	CcSEcCtD
Estropipate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000284	0.000614	CcSEcCtD
Estropipate—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000282	0.00708	CbGpPWpGaD
Estropipate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000604	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000603	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000599	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000598	CcSEcCtD
Estropipate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.000596	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000275	0.00691	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000275	0.000594	CcSEcCtD
Estropipate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000274	0.000593	CcSEcCtD
Estropipate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.000592	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000591	CcSEcCtD
Estropipate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000591	CcSEcCtD
Estropipate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000587	CcSEcCtD
Estropipate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000586	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000271	0.0068	CbGpPWpGaD
Estropipate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00027	0.000584	CcSEcCtD
Estropipate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.000583	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000268	0.00674	CbGpPWpGaD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000268	0.00674	CbGpPWpGaD
Estropipate—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000579	CcSEcCtD
Estropipate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000267	0.000577	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000575	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000266	0.000574	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000266	0.000574	CcSEcCtD
Estropipate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000264	0.00057	CcSEcCtD
Estropipate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000263	0.000569	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000569	CcSEcCtD
Estropipate—Rash—Vincristine—peripheral nervous system neoplasm	0.000261	0.000566	CcSEcCtD
Estropipate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000261	0.000565	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000565	CcSEcCtD
Estropipate—Headache—Vincristine—peripheral nervous system neoplasm	0.00026	0.000562	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000559	CcSEcCtD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000257	0.00647	CbGpPWpGaD
Estropipate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000554	CcSEcCtD
Estropipate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.000553	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000553	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000255	0.0064	CbGpPWpGaD
Estropipate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000543	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000542	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000536	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000247	0.000535	CcSEcCtD
Estropipate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000246	0.000533	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000532	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000532	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000527	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000523	CcSEcCtD
Estropipate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000241	0.000521	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00052	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000518	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000517	CcSEcCtD
Estropipate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000238	0.000514	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000511	CcSEcCtD
Estropipate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000507	CcSEcCtD
Estropipate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000504	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000502	CcSEcCtD
Estropipate—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	0.000232	0.00583	CbGpPWpGaD
Estropipate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000502	CcSEcCtD
Estropipate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000231	0.0005	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000231	0.0005	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000499	CcSEcCtD
Estropipate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000499	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00023	0.000497	CcSEcCtD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000229	0.00576	CbGpPWpGaD
Estropipate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000496	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000492	CcSEcCtD
Estropipate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000492	CcSEcCtD
Estropipate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00049	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000224	0.00564	CbGpPWpGaD
Estropipate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000485	CcSEcCtD
Estropipate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000483	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000481	CcSEcCtD
Estropipate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000222	0.000481	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00048	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000479	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000478	CcSEcCtD
Estropipate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000471	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000469	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000465	CcSEcCtD
Estropipate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000214	0.000462	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000462	CcSEcCtD
Estropipate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000462	CcSEcCtD
Estropipate—Rash—Etoposide—peripheral nervous system neoplasm	0.000212	0.000458	CcSEcCtD
Estropipate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000212	0.000458	CcSEcCtD
Estropipate—Headache—Etoposide—peripheral nervous system neoplasm	0.00021	0.000455	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000455	CcSEcCtD
Estropipate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000453	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000449	CcSEcCtD
Estropipate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000448	CcSEcCtD
Estropipate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000447	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000444	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000204	0.00513	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.000204	0.00513	CbGpPWpGaD
Estropipate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000441	CcSEcCtD
Estropipate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000436	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000201	0.00504	CbGpPWpGaD
Estropipate—Nausea—Etoposide—peripheral nervous system neoplasm	0.0002	0.000432	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000199	0.005	CbGpPWpGaD
Estropipate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000425	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000425	CcSEcCtD
Estropipate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000423	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000422	CcSEcCtD
Estropipate—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000193	0.00484	CbGpPWpGaD
Estropipate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000415	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000408	CcSEcCtD
Estropipate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000407	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000407	CcSEcCtD
Estropipate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000405	CcSEcCtD
Estropipate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000403	CcSEcCtD
Estropipate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000186	0.00467	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000186	0.00466	CbGpPWpGaD
Estropipate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000399	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000183	0.00461	CbGpPWpGaD
Estropipate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000396	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000182	0.00457	CbGpPWpGaD
Estropipate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000393	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000393	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000181	0.00456	CbGpPWpGaD
Estropipate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000392	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00039	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.000178	0.00448	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000178	0.00448	CbGpPWpGaD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000177	0.00445	CbGpPWpGaD
Estropipate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000377	CcSEcCtD
Estropipate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000377	CcSEcCtD
Estropipate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000374	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000173	0.00434	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000371	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00037	CcSEcCtD
Estropipate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000368	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000366	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000366	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000169	0.00425	CbGpPWpGaD
Estropipate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000362	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000166	0.00418	CbGpPWpGaD
Estropipate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000359	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000352	CcSEcCtD
Estropipate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000351	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000162	0.00406	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.000161	0.00405	CbGpPWpGaD
Estropipate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000348	CcSEcCtD
Estropipate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000348	CcSEcCtD
Estropipate—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00016	0.00403	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000343	CcSEcCtD
Estropipate—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000158	0.00396	CbGpPWpGaD
Estropipate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000341	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000338	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000335	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000333	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000332	CcSEcCtD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000153	0.00384	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000152	0.00381	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000151	0.00381	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000325	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000325	CcSEcCtD
Estropipate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000324	CcSEcCtD
Estropipate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Estropipate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000147	0.00368	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000146	0.00366	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000308	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000139	0.00349	CbGpPWpGaD
Estropipate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000139	0.0003	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000299	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000298	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000298	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000137	0.00345	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000136	0.00343	CbGpPWpGaD
Estropipate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000292	CcSEcCtD
Estropipate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000288	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000133	0.00334	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.00013	0.00326	CbGpPWpGaD
Estropipate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000279	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000129	0.00323	CbGpPWpGaD
Estropipate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000278	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00027	CcSEcCtD
Estropipate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000269	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.000124	0.00311	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000123	0.0031	CbGpPWpGaD
Estropipate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000267	CcSEcCtD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000122	0.00306	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000122	0.00306	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000121	0.00304	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000121	0.00303	CbGpPWpGaD
Estropipate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000259	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000258	CcSEcCtD
Estropipate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000257	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000257	CcSEcCtD
Estropipate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000255	CcSEcCtD
Estropipate—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	0.000117	0.00294	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000117	0.00294	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000116	0.00291	CbGpPWpGaD
Estropipate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000249	CcSEcCtD
Estropipate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000242	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00024	CcSEcCtD
Estropipate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000238	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000237	CcSEcCtD
Estropipate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000236	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000107	0.0027	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000107	0.0027	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000224	CcSEcCtD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000101	0.00254	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	9.92e-05	0.00249	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	9.36e-05	0.00235	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	9.17e-05	0.0023	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	8.98e-05	0.00226	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.81e-05	0.00221	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.63e-05	0.00217	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	8.57e-05	0.00215	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.54e-05	0.00215	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.37e-05	0.0021	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.22e-05	0.00206	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	8.15e-05	0.00205	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.14e-05	0.00204	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	7.93e-05	0.00199	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.83e-05	0.00197	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	7.66e-05	0.00193	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.64e-05	0.00192	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	7.45e-05	0.00187	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.44e-05	0.00187	CbGpPWpGaD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	7.33e-05	0.00184	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	7.14e-05	0.00179	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.12e-05	0.00179	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	6.97e-05	0.00175	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.93e-05	0.00174	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.66e-05	0.00167	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	6.53e-05	0.00164	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	6.28e-05	0.00158	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.19e-05	0.00156	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	5.94e-05	0.00149	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	5.7e-05	0.00143	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.69e-05	0.00143	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	5.61e-05	0.00141	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.5e-05	0.00138	CbGpPWpGaD
Estropipate—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.5e-05	0.00138	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	5.48e-05	0.00138	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.41e-05	0.00136	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	5.36e-05	0.00135	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.33e-05	0.00134	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.28e-05	0.00133	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	5.1e-05	0.00128	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.98e-05	0.00125	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.89e-05	0.00123	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.75e-05	0.00119	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.57e-05	0.00115	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.53e-05	0.00114	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	4.51e-05	0.00113	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.5e-05	0.00113	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.44e-05	0.00112	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	4.4e-05	0.00111	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.39e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.17e-05	0.00105	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.14e-05	0.00104	CbGpPWpGaD
Estropipate—ALB—Metabolism—GNS—peripheral nervous system neoplasm	3.97e-05	0.000999	CbGpPWpGaD
Estropipate—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	3.85e-05	0.000968	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.85e-05	0.000967	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.84e-05	0.000966	CbGpPWpGaD
Estropipate—ALB—Metabolism—NME1—peripheral nervous system neoplasm	3.81e-05	0.000957	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.75e-05	0.000943	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.74e-05	0.000939	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.7e-05	0.000929	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	3.67e-05	0.000922	CbGpPWpGaD
Estropipate—ALB—Metabolism—COX2—peripheral nervous system neoplasm	3.67e-05	0.000921	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.6e-05	0.000904	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.33e-05	0.000838	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.27e-05	0.000822	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	3.25e-05	0.000817	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.2e-05	0.000803	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	3.12e-05	0.000784	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.04e-05	0.000764	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	3e-05	0.000754	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.97e-05	0.000746	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.9e-05	0.000729	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.89e-05	0.000726	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	2.86e-05	0.000718	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.83e-05	0.000712	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.78e-05	0.000698	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.69e-05	0.000675	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.68e-05	0.000672	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.66e-05	0.00067	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	2.57e-05	0.000645	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.57e-05	0.000645	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.47e-05	0.000621	CbGpPWpGaD
Estropipate—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	2.41e-05	0.000605	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.36e-05	0.000592	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.33e-05	0.000586	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.29e-05	0.000576	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.16e-05	0.000543	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.15e-05	0.000539	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.06e-05	0.000517	CbGpPWpGaD
Estropipate—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.03e-05	0.000511	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000507	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.98e-05	0.000497	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.97e-05	0.000495	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.94e-05	0.000488	CbGpPWpGaD
Estropipate—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.91e-05	0.000481	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000447	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.68e-05	0.000423	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.67e-05	0.000418	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.61e-05	0.000404	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.59e-05	0.000399	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.57e-05	0.000393	CbGpPWpGaD
Estropipate—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-05	0.000392	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-05	0.000385	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000378	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.42e-05	0.000358	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.36e-05	0.000341	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.34e-05	0.000336	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.3e-05	0.000327	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	1.29e-05	0.000325	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000321	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000315	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.23e-05	0.000309	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	0.000298	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.18e-05	0.000296	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.1e-05	0.000276	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000274	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	0.000271	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.000269	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000263	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000261	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000259	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.03e-06	0.000227	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	8.98e-06	0.000226	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	8.43e-06	0.000212	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.42e-06	0.000211	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	8.27e-06	0.000208	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.91e-06	0.000174	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.61e-06	0.000166	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.3e-06	0.000158	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.84e-06	0.000147	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	4.21e-06	0.000106	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	3.45e-06	8.67e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.95e-06	7.41e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.28e-06	5.72e-05	CbGpPWpGaD
